{"id":"glutamin","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":{"chemblId":"CHEMBL930","moleculeType":"Small molecule","molecularWeight":"146.15"},"aliases":["L-glutamine"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"ad5728b6-d9de-4eac-8a2f-923ddf983c7d","title":"L-GLUTAMINE HIGH 7406 (L-GLUTAMINE HIGH) LIQUID [PROFESSIONAL COMPLEMENTARY HEALTH FORMULAS]"},"ecosystem":[],"mechanism":{"target":"Amino acid transporter"},"_scrapedAt":"2026-03-28T01:14:04.992Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Short bowel syndrome","diseaseId":"short-bowel-syndrome","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06718153","phase":"NA","title":"Immunohistochemical Algorithm for the Diagnosis and Classification of Hepatocellular Carcinomas With TERT, TP53 and CTNNB1 Mutation","status":"RECRUITING","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2024-10-23","conditions":"Hepatic Cancer, Hepatic Resection","enrollment":100},{"nctId":"NCT04693936","phase":"NA","title":"Metabolic Biomarkers in Hashimoto's Thyroiditis and Psoriasis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Crete","startDate":"2021-02-02","conditions":"Hashimoto Disease, Psoriasis","enrollment":200},{"nctId":"NCT03917095","phase":"NA","title":"The Safety and Efficacy of TET Enema in the Treatment of UC","status":"UNKNOWN","sponsor":"The Second Hospital of Nanjing Medical University","startDate":"2019-05-15","conditions":"Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate","enrollment":75},{"nctId":"NCT02998931","phase":"PHASE3","title":"Trial of Enteral Glutamine on Clinical Outcomes in Critically Ill Patients","status":"COMPLETED","sponsor":"Shahid Beheshti University","startDate":"2016-11-10","conditions":"Critical Illness, Enteral Nutrition, Multiple Organ Failure","enrollment":200},{"nctId":"NCT03113240","phase":"PHASE3","title":"Trial of Enteral Glutamine on Intestinal Permeability in Critically Ill Patients","status":"COMPLETED","sponsor":"Shahid Beheshti University","startDate":"2017-04-01","conditions":"Critical Illness, Enteral Nutrition, Intestinal Permeability","enrollment":60},{"nctId":"NCT01552291","phase":"PHASE4","title":"The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoing Major Abdominal Surgery Due to Malignancies","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2012-05","conditions":"Malnourishment, Gastrointestinal Tumors","enrollment":42},{"nctId":"NCT01955772","phase":"PHASE3","title":"Randomized, Prospective, Multicenter Study to Compare Enteral Nutrition to Parenteral Nutrition as Feeding Support in Patients Presenting Malignant Hemopathy Who Underwent an Allogeneic Hematopoietic Stem Cell Transplantation.","status":"UNKNOWN","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2013-11","conditions":"Myeloablative Allo-SCT","enrollment":240},{"nctId":"NCT01157039","phase":"PHASE2","title":"A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin","status":"WITHDRAWN","sponsor":"AHS Cancer Control Alberta","startDate":"2011-10","conditions":"Colorectal Carcinoma, Neoplasms, Colorectal, Colorectal Cancer","enrollment":""},{"nctId":"NCT02444780","phase":"","title":"Observational Study on Plasma Glutamine Levels Before and After Cardiac Surgery","status":"COMPLETED","sponsor":"Frisius Medisch Centrum","startDate":"2015-06","conditions":"Glutamin Level","enrollment":90},{"nctId":"NCT01353638","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solution in Peritoneal Dialysis","status":"TERMINATED","sponsor":"Christoph Aufricht","startDate":"2011-04","conditions":"End Stage Renal Disease","enrollment":25},{"nctId":"NCT01478126","phase":"PHASE3","title":"Effects of Glutamine in Ischemic Heart Disease Patients Following Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2012-01","conditions":"Coronary Artery Disease","enrollment":24}],"_emaApprovals":[],"_faersSignals":[{"count":9,"reaction":"FATIGUE"},{"count":5,"reaction":"OROPHARYNGEAL PAIN"},{"count":5,"reaction":"VOMITING"},{"count":4,"reaction":"INSOMNIA"},{"count":4,"reaction":"NAUSEA"},{"count":4,"reaction":"PAIN IN EXTREMITY"},{"count":4,"reaction":"PYREXIA"},{"count":3,"reaction":"ASTHENIA"},{"count":3,"reaction":"COUGH"},{"count":3,"reaction":"DRUG INEFFECTIVE"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":68,"therapeuticAreas":["Gastroenterology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Glutamin","genericName":"Glutamin","companyName":"Shahid Beheshti University","companyId":"shahid-beheshti-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":4,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}